DNA content in renal cell carcinoma with reference to tumor heterogeneity
- PMID: 4005812
- DOI: 10.1002/1097-0142(19850801)56:3<503::aid-cncr2820560316>3.0.co;2-n
DNA content in renal cell carcinoma with reference to tumor heterogeneity
Abstract
DNA content was successfully determined by flow cytometry in 196 tissue samples from 25 renal cell carcinomas. Twelve tumors (48%) were homogeneously diploid/near-diploid, whereas 11 tumors were aneuploid and 2 tumors were polyploid. Cell clones with different DNA content were found in 11 tumors demonstrating a considerable heterogeneity in the non-diploid tumors; 9 of these 11 heterogeneous tumors contained both aneuploid and diploid cell clones. Tumor samples morphologically classified as grade 1 and 2 were 98% diploid and grade 4 samples were 78% aneuploid. No correlation between DNA distribution and morphologic grade was found for grade 3 tumor samples. Tumor proliferation rate, as determined by the fraction of cells in S-phase, was significantly higher in aneuploid samples compared to normal kidney tissue samples and diploid tumor samples.
Similar articles
-
Heterogeneity and progression of renal cell carcinomas as revealed by DNA cytofluorometry and the significance of the presence of polyploid cells.Urol Res. 1995;23(6):381-6. doi: 10.1007/BF00698739. Urol Res. 1995. PMID: 8788276
-
[Tumor heterogeneity of renal cell carcinoma as analyzed by flow cytometry].Nihon Hinyokika Gakkai Zasshi. 1990 Apr;81(4):593-600. doi: 10.5980/jpnjurol1989.81.593. Nihon Hinyokika Gakkai Zasshi. 1990. PMID: 2374332 Japanese.
-
DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.Scand J Urol Nephrol Suppl. 1986;100:1-47. Scand J Urol Nephrol Suppl. 1986. PMID: 3472340
-
In vivo aneuploidization during the expansion of renal adenocarcinoma.Urol Int. 2011;86(4):466-9. doi: 10.1159/000324101. Epub 2011 May 5. Urol Int. 2011. PMID: 21546757
-
Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.Scand J Urol Nephrol Suppl. 1994;165:1-48. Scand J Urol Nephrol Suppl. 1994. PMID: 7871395
Cited by
-
Inter and intratumour heterogeneity: a barrier to individualized medical therapy in renal cell carcinoma?Front Oncol. 2012 May 18;2:49. doi: 10.3389/fonc.2012.00049. eCollection 2012. Front Oncol. 2012. PMID: 22655275 Free PMC article. No abstract available.
-
Nuclear grading of renal cell carcinomas--is morphometry necessary?J Cancer Res Clin Oncol. 1991;117(1):73-8. doi: 10.1007/BF01613201. J Cancer Res Clin Oncol. 1991. PMID: 1997475 Free PMC article.
-
Prognostic indicators in centroblastic-centrocytic lymphoma.J Clin Pathol. 1988 Aug;41(8):866-70. doi: 10.1136/jcp.41.8.866. J Clin Pathol. 1988. PMID: 3170773 Free PMC article.
-
Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.Br J Cancer. 1996 Jul;74(1):123-7. doi: 10.1038/bjc.1996.326. Br J Cancer. 1996. PMID: 8679445 Free PMC article.
-
Flow cytometric analysis of the nuclear DNA content of hepatocellular carcinoma.Jpn J Surg. 1989 Nov;19(6):662-73. doi: 10.1007/BF02471716. Jpn J Surg. 1989. PMID: 2558244
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical